PRIA Logo™
S3697119th CongressWALLET

SAVE Moms and Babies Act of 2026

Sponsored By: Senator Hyde-Smith, Cindy [R-MS]

Introduced

Summary

Tightens federal control over abortion drugs. This bill would bar new FDA approvals and create strict limits on labeling, dispensing, practitioner certification, and safety reporting for medical abortion drugs.

Show full summary
  • Pregnant people would face a 70 day gestation cap for labeled use and must receive the drug in person from the prescribing clinician. Prescribers must give written risk information and secure the patient's acknowledgment.
  • Prescribing clinicians would need certification to assess gestational duration, diagnose ectopic pregnancies, provide surgical care for incomplete abortion or severe bleeding, and ensure access to facilities that can give blood transfusions and resuscitation. Clinicians could not dispense these drugs in the role of a pharmacist.
  • The FDA would be barred from approving new marketing applications under sections 505(b) and 505(j) for abortion drugs and from granting investigational exemptions under 505(i). Manufacturers and prescribers must report all known adverse events to the FDA and to manufacturers without including identifiable patient information.

Personalized for You

How does this bill affect your finances?

Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Free to download

Bill Overview

Analyzed Economic Effects

1 provisions identified: 0 benefits, 1 costs, 0 mixed.

New restrictions on medication abortion access

If enacted, the bill would bar the HHS Secretary from approving new marketing applications for any "abortion drug" and would ban new investigational-use exemptions for such drugs or studies that knowingly destroy an unborn child. Any investigational exemption granted before enactment would be rescinded three years after enactment if the Secretary would then be barred from issuing it. For abortion drugs already approved on the date of enactment, the bill would impose strict safety controls (a REMS), bar use after 70 days gestation, and require in-person administration by the prescribing clinician in a clinic, medical office, or hospital (not in pharmacies). Prescribers would need certification, be able to assess gestational age and diagnose ectopic pregnancy, ensure access to surgical care and blood transfusion or resuscitation if needed, give patients written risk information and get acknowledgment, and manufacturers and clinicians would have to report serious adverse events to FDA (excluding individually identifiable patient details).

Sponsors & CoSponsors

Sponsor

Hyde-Smith, Cindy [R-MS]

MS • R

Cosponsors

  • Sen. Daines, Steve [R-MT]

    MT • R

    Sponsored 1/27/2026

  • Sen. Risch, James E. [R-ID]

    ID • R

    Sponsored 1/27/2026

  • Sen. Rounds, Mike [R-SD]

    SD • R

    Sponsored 1/27/2026

  • Sen. Wicker, Roger F. [R-MS]

    MS • R

    Sponsored 1/27/2026

  • Sen. Lankford, James [R-OK]

    OK • R

    Sponsored 1/27/2026

  • Sen. McConnell, Mitch [R-KY]

    KY • R

    Sponsored 1/27/2026

  • Sen. Lummis, Cynthia M. [R-WY]

    WY • R

    Sponsored 1/27/2026

  • Sen. Cruz, Ted [R-TX]

    TX • R

    Sponsored 1/27/2026

  • Sen. Banks, Jim [R-IN]

    IN • R

    Sponsored 1/27/2026

  • Sen. Marshall, Roger [R-KS]

    KS • R

    Sponsored 1/27/2026

  • Sen. Britt, Katie Boyd [R-AL]

    AL • R

    Sponsored 1/27/2026

  • Sen. Scott, Rick [R-FL]

    FL • R

    Sponsored 1/27/2026

  • Sen. Hawley, Josh [R-MO]

    MO • R

    Sponsored 1/27/2026

  • Sen. Crapo, Mike [R-ID]

    ID • R

    Sponsored 1/27/2026

  • Sen. Budd, Ted [R-NC]

    NC • R

    Sponsored 1/27/2026

  • Sen. Graham, Lindsey [R-SC]

    SC • R

    Sponsored 1/27/2026

  • Sen. Cassidy, Bill [R-LA]

    LA • R

    Sponsored 1/27/2026

  • Sen. Cornyn, John [R-TX]

    TX • R

    Sponsored 1/27/2026

  • Sen. Ernst, Joni [R-IA]

    IA • R

    Sponsored 1/27/2026

  • Sen. Lee, Mike [R-UT]

    UT • R

    Sponsored 1/27/2026

  • Sen. Cramer, Kevin [R-ND]

    ND • R

    Sponsored 1/27/2026

  • Sen. Ricketts, Pete [R-NE]

    NE • R

    Sponsored 1/27/2026

  • Sen. Fischer, Deb [R-NE]

    NE • R

    Sponsored 1/27/2026

  • Sen. Kennedy, John [R-LA]

    LA • R

    Sponsored 1/27/2026

  • Sen. Hoeven, John [R-ND]

    ND • R

    Sponsored 1/27/2026

  • Sen. Young, Todd [R-IN]

    IN • R

    Sponsored 1/27/2026

  • Sen. Hagerty, Bill [R-TN]

    TN • R

    Sponsored 1/27/2026

  • Sen. Cotton, Tom [R-AR]

    AR • R

    Sponsored 1/27/2026

  • Sen. Moran, Jerry [R-KS]

    KS • R

    Sponsored 1/27/2026

  • Sen. Blackburn, Marsha [R-TN]

    TN • R

    Sponsored 1/27/2026

  • Sen. Barrasso, John [R-WY]

    WY • R

    Sponsored 3/25/2026

  • Sen. Tuberville, Tommy [R-AL]

    AL • R

    Sponsored 4/27/2026

  • Sen. Thune, John [R-SD]

    SD • R

    Sponsored 5/13/2026

  • Sen. Boozman, John [R-AR]

    AR • R

    Sponsored 6/22/2026

  • Sen. Graham, Darline [R-SC]

    SC • R

    Sponsored 7/22/2026

  • Sen. Scott, Tim [R-SC]

    SC • R

    Sponsored 8/3/2026

  • Sen. McCormick, David [R-PA]

    PA • R

    Sponsored 8/3/2026

Roll Call Votes

No roll call votes available for this bill.

View on Congress.gov
Back to Legislation